v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
REVENUES:    
Revenues $ 29,103,093 $ 16,048,618
Cost of product revenue 25,441,046 17,770,122
Gross profit (loss) 3,662,047 (1,721,504)
OPERATING EXPENSES:    
Research and development 624,111 987,649
Plasma center operating expenses 3,974,589 2,242,343
Amortization of intangible assets 178,838 178,838
Selling, general and administrative 13,699,575 10,033,915
Total operating expenses 18,477,113 13,442,745
LOSS FROM OPERATIONS (14,815,066) (15,164,249)
OTHER INCOME (EXPENSE):    
Interest income 33,068 22,059
Interest expense (3,389,038) (3,195,750)
Loss on extinguishment of debt (6,669,941) 0
Other expense (166,880) (42,001)
Other expense, net (10,192,791) (3,215,692)
NET LOSS $ (25,007,857) $ (18,379,941)
BASIC LOSS PER COMMON SHARE (in dollars per share) $ (0.13) $ (0.16)
DILUTED LOSS PER COMMON SHARE (in dollars per share) $ (0.13) $ (0.16)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:    
Basic (in shares) 195,871,932 115,661,937
Diluted (in shares) 195,871,932 115,661,937
Product Revenue [Member]    
REVENUES:    
Revenues $ 29,067,385 $ 16,012,910
License Revenue [Member]    
REVENUES:    
Revenues $ 35,708 $ 35,708

Source